Uploaded image for project: 'FHIR Specification Feedback'
  1. FHIR Specification Feedback
  2. FHIR-20198

Medication Impact profile obs-med-impact (CG IG)

    XMLWordPrintableJSON

    Details

    • Type: Change Request
    • Status: Triaged (View Workflow)
    • Priority: Medium
    • Resolution: Unresolved

      Description

      The required "medication assessed" component needs to be able to have a recommendation proposal from the lab. Each medication assessed for a given derived pgx genotype or complex diplotype finding that has a metabolic, transporter or efficacy impact should also be able to have a text and url recommendation. Many PGX results show several drug-recommendations for a single PGX metab, efficacy or transporter impact.

      For example

      CYP2C19 *2/*2 may be a Poor Metabolizer for the following

      1) clipidogrel - https://cpicpgx.org/guidelines/guideline-for-clopidogrel-and-cyp2c19/ - lab text abstract of interp/recommendation
      2) voriconaxzole - https://cpicpgx.org/guidelines/guideline-for-voriconazole-and-cyp2c19/ - Lab text abstract of this
      3) citalopram, escitalopram - https://cpicpgx.org/guidelines/guideline-for-selective-serotonin-reuptake-inhibitors-and-cyp2d6-and-cyp2c19/ - lab abstract
      4)amitriptyline , etc..

      ...

        Attachments

          Activity

            People

            Assignee:
            Unassigned Unassigned
            Reporter:
            lbabb Larry Babb
            Watchers:
            2 Start watching this issue

              Dates

              Created:
              Updated: